Dane Andreeff bought $40k of HSDT
President and CEO at HELIUS MEDICAL TECHNOLOGIES, INC.. 5,000 shares at an average of $8.10, traded Dec 14, 2023, filed Dec 15, 2023.
Score components
- +25RoleCEO
- +6Trade size$40k at market
- +6Relative to holdingsHoldings up 37%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying3 buys in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001140361-23-057794, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 14, 2023 | POpen-market purchase Common Stockindirect: See footnote | +2,827 | $8.10 | $23k | 16,512 | Dec 15, 2023 |
| Dec 14, 2023 | POpen-market purchase Common Stockindirect: See footnote | +570 | $8.10 | $4,614 | 3,402 | Dec 15, 2023 |
| Dec 14, 2023 | POpen-market purchase Common Stockindirect: See footnote | +1,603 | $8.10 | $13k | 12,879 | Dec 15, 2023 |
Related signals
Other insiders at HELIUS MEDICAL TECHNOLOGIES, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 35Weak | HSDTbuy HELIUS MEDICAL TECHNOLOGIES, INC. | Dane Andreeff President and CEO | $8,229 1,284 shares | +215% | |
| 36Weak | HSDTbuy HELIUS MEDICAL TECHNOLOGIES, INC. | Dane Andreeff President and CEO | $26k 4,006 shares | +35% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.